Related Experiment Video
Updated: Apr 18, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Renal denervation: unde venis et quo vadis?
Renal denervation shows limited efficacy for refractory hypertension, with initial trials showing significant blood pressure reduction not confirmed in randomized studies. Further evaluation is needed before widespread use outside clinical trials.
Area of Science:
- Cardiology
- Nephrology
- Interventional Radiology
Background:
- Refractory hypertension affects a small percentage of hypertensive patients.
- Renal denervation is a minimally invasive procedure targeting the renal sympathetic nerves.
- Established indications and contraindications guide its use.
Purpose of the Study:
- To evaluate the efficacy and safety of renal denervation for treating refractory hypertension.
- To assess the procedure's effectiveness in patients with primary hypertension and diabetes mellitus type 2.
- To determine if renal denervation offers superior outcomes compared to optimal medical therapy.
Main Methods:
- Review of indications and contraindications for renal denervation.
- Analysis of results from non-randomized and randomized controlled trials.
- Comparison of blood pressure reduction in renal denervation versus sham procedures.
Main Results:
- Non-randomized trials indicated an average blood pressure reduction of 32/14 mmHg.
- The first randomized controlled trial showed a non-significant blood pressure reduction of 14.1 mmHg compared to controls.
- Office blood pressure decreased significantly, but 24-hour ambulatory blood pressure impact remains unclear.
Conclusions:
- Efficacy and long-term effects of renal denervation require re-evaluation, particularly after the HTN3 study.
- Renal denervation should be limited to clinical trials currently.
- Further research is needed to assess safety and efficacy in hypertension-associated diseases and as an alternative therapy.
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Diabetic Nephropathy
Blood and Nerve Supply to the Kidney
Bloody Supply to the Kidneys:
The kidneys receive their blood supply from the renal arteries, which branch off from the abdominal aorta—the main artery supplying the abdomen and lower body. The renal arteries enter the kidneys at the hilum, a notch on the medial side of...
Imaging Studies VII: Vascular Imaging
Heart Failure Drugs: Diuretics